Insights

News Show all

News

New Horizons in Bioinformatics

Lab Visit at the Huttenhower Lab, USA

Alba is associate scientist at the RU 5042 miTarget and doctoral researcher at the Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU). She received one ofread more

Events Show all

Our mission

Patterns of gut microbiome dysbiosis in patients with inflammatory bowel diseases are inconsistent among published studies, probably owing to the heterogeneity of the disease and given the fact that patients enrolled in research studies are often treated and in remission. Therefore, more microbiome studies in “early” (incident) patients that are treatment-naïve and in high-risk individuals are needed. In addition, the microbiome field has to move from association to rather mechanistic studies in order to understand the actual functions and to also prove the associations that serve as hypotheses.

Institute of Clinical Molecular Biology
Kiel University
Rosalind-Franklin-Str. 12
24105 Kiel

Spokesperson
Prof. Dr. rer. nat. Andre Franke
Fon: +49(0)431-500-15112
a.franke@ikmb-uni-kiel.de

Coordination
Annika Gröning
Fon: +49 (0)431 500-15115
a.groening@ikmb.uni-kiel.de

Doctoral qualification programme
Eike Zell
Fon: +49 (0)431 500-15113
e.zell@ikmb.uni-kiel.de

Participating Institutes